Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Li_2019_J.Med.Chem_62_2348

Reference

Title: Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes
Li S, Qin C, Cui S, Xu H, Wu F, Wang J, Su M, Fang X, Li D and Li H <8 more author(s)>
Ref: Journal of Medicinal Chemistry, 62:2348, 2019 : PubMed

        



Related information

Gene_Locus| human-DPP4
Structure in RCSB-PDB | 5ZID, 5J3J
Structure in ESTHER | 5ZID, 5J3J
Inhibitor | HL2,


Citations formats

Li S, Qin C, Cui S, Xu H, Wu F, Wang J, Su M, Fang X, Li D, Jiao Q, Zhang M, Xia C, Zhu L, Wang R, Li J, Jiang H, Zhao Z, Li H (2019)
Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes
Journal of Medicinal Chemistry 62: 2348-2361

Li S, Qin C, Cui S, Xu H, Wu F, Wang J, Su M, Fang X, Li D, Jiao Q, Zhang M, Xia C, Zhu L, Wang R, Li J, Jiang H, Zhao Z, Li H (2019)
Journal of Medicinal Chemistry 62: 2348-2361



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer